ADMA Biologics Inc. Facing Securities Fraud Investigation
If you’re an investor in ADMA Biologics, Inc. (NASDAQ: ADMA), you’ll want to pay attention to this. The Schall Law Firm, a national shareholder rights litigation firm, is looking into potential securities law violations by the company.
According to the investigation, ADMA Biologics may have made false and misleading statements to the market. The company recently disclosed the sudden departure of its independent outside auditor, CohnReznick LLP., on October 9, leading to a more than 16.3% drop in its share price the following day.
If you’re an impacted investor, you’re encouraged to reach out to Brian Schall of the Schall Law Firm. You can contact him at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, call 310-301-3335, or visit www.schallfirm.com to discuss your rights free of charge. The Schall Law Firm focuses on securities class action lawsuits and shareholder rights litigation, representing investors worldwide.
Remember, this information is not legal advice, but rather a heads-up about the ongoing investigation. Stay informed and know your options.
